Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» eteplirsen
eteplirsen
What You Need to Know About PTC Therapeutics' Promising DMD Drug
Motley Fool
Thu, 06/5/14 - 11:19 am
Duchenne Muscular Dystrophy
PTC Therapeutics
eteplirsen
Sarepta gearing for potential 2015 launch of eteplirsen, says Piper Jaffray
The Fly on the Wall
Thu, 05/22/14 - 11:54 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta's Still a Gamble, Even With FDA Reversal
Motley Fool
Fri, 04/25/14 - 08:31 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Sarepta Surges on Optimism Over Muscular Dystrophy Drug
Bloomberg
Mon, 04/21/14 - 10:32 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics on Cusp of Huge Eteplirsen News
TheStreet.com
Tue, 04/8/14 - 05:16 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Why Sarepta Therapeutics Inc. Might Have a Fighting Chance
Motley Fool
Wed, 03/5/14 - 11:53 am
Sarepta Therapeutics
eteplirsen
Sarepta jumps on fresh optimism for an early approval
Fierce Biotech
Thu, 01/16/14 - 11:34 am
Sarepta
Duchenne Muscular Dystrophy
eteplirsen
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind
TheStreet.com
Mon, 01/6/14 - 04:25 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014
Seeking Alpha
Thu, 12/26/13 - 09:43 am
eteplirsen
Sarepta Therapeutics
Duchenne Muscular Dystrophy
November's 3 Biggest Biotech Busts
Motley Fool
Mon, 12/2/13 - 08:31 am
Immunogen
Aegerion
eteplirsen
Sarepta Therapeutics
Biotech Stock Roundup: Vanda Soars, Sarepta Slumps
Yahoo/Zacks.com
Wed, 11/20/13 - 11:47 am
Vanda
Sarepta Therapeutics
tasimelteon
Hetlioz
Duchenne Muscular Dystrophy
eteplirsen
Eteplirsen in Question: Hope for Sarepta
Motley Fool
Fri, 11/15/13 - 09:51 am
eteplirsen
Sarepta Therapeutics
Duchenne Muscular Dystrophy
What The Delay Of A Promising Muscular Dystrophy Drug Means For Patients, Investors And All Of Biotech
Forbes
Tue, 11/12/13 - 04:32 pm
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics
Why You Should Be Watching Sarepta, Hologic, and Achillion Today
Motley Fool
Tue, 11/12/13 - 09:41 am
Achillion
Sarepta Therapeutics
Hologic
earnings
eteplirsen
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen
TheStreet.com
Tue, 11/12/13 - 07:59 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
3 Promising Biotech Stocks with Upcoming Catalysts
Wall St. Cheat Sheet
Mon, 11/4/13 - 10:08 am
Sarepta Therapeutics
eteplirsen
NeoStem
AMR-001
Celldex
CDX-110
Short Sarepta: DMD Drug Prognosis Is Dismal
Seeking Alpha
Wed, 10/30/13 - 09:35 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
This Slide Paints Grim Picture of Glaxo, Prosensa's DMD Drug
TheStreet.com
Mon, 10/7/13 - 08:57 am
GSK
Prosensa
Duchenne Muscular Dystrophy
drisapersen
Sarepta Therapeutics
eteplirsen
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »